JP2020078318A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020078318A5 JP2020078318A5 JP2020015937A JP2020015937A JP2020078318A5 JP 2020078318 A5 JP2020078318 A5 JP 2020078318A5 JP 2020015937 A JP2020015937 A JP 2020015937A JP 2020015937 A JP2020015937 A JP 2020015937A JP 2020078318 A5 JP2020078318 A5 JP 2020078318A5
- Authority
- JP
- Japan
- Prior art keywords
- isfahan
- virus
- antigen
- protein
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022095401A JP2022126723A (ja) | 2014-03-01 | 2022-06-14 | 組換えイスファハンウイルスベクター |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461946734P | 2014-03-01 | 2014-03-01 | |
| US61/946,734 | 2014-03-01 | ||
| JP2016555578A JP2017508465A (ja) | 2014-03-01 | 2015-02-27 | 組換えイスファハンウイルスベクター |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016555578A Division JP2017508465A (ja) | 2014-03-01 | 2015-02-27 | 組換えイスファハンウイルスベクター |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022095401A Division JP2022126723A (ja) | 2014-03-01 | 2022-06-14 | 組換えイスファハンウイルスベクター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020078318A JP2020078318A (ja) | 2020-05-28 |
| JP2020078318A5 true JP2020078318A5 (cg-RX-API-DMAC10.html) | 2021-03-18 |
| JP7454393B2 JP7454393B2 (ja) | 2024-03-22 |
Family
ID=54055975
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016555578A Pending JP2017508465A (ja) | 2014-03-01 | 2015-02-27 | 組換えイスファハンウイルスベクター |
| JP2020015937A Active JP7454393B2 (ja) | 2014-03-01 | 2020-02-03 | 組換えイスファハンウイルスベクター |
| JP2022095401A Pending JP2022126723A (ja) | 2014-03-01 | 2022-06-14 | 組換えイスファハンウイルスベクター |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016555578A Pending JP2017508465A (ja) | 2014-03-01 | 2015-02-27 | 組換えイスファハンウイルスベクター |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022095401A Pending JP2022126723A (ja) | 2014-03-01 | 2022-06-14 | 組換えイスファハンウイルスベクター |
Country Status (14)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11364292B2 (en) | 2015-07-21 | 2022-06-21 | Modernatx, Inc. | CHIKV RNA vaccines |
| WO2017070624A1 (en) | 2015-10-22 | 2017-04-27 | Modernatx, Inc. | Tropical disease vaccines |
| MA49421A (fr) | 2017-06-15 | 2020-04-22 | Modernatx Inc | Formulations d'arn |
| MX2020002348A (es) | 2017-08-31 | 2020-10-08 | Modernatx Inc | Métodos de elaboración de nanopartículas lipídicas. |
| EP3681514A4 (en) | 2017-09-14 | 2021-07-14 | ModernaTX, Inc. | RNA VACZINE AGAINST ZIKA VIRUS |
| EP3681523A4 (en) * | 2017-09-15 | 2021-12-29 | The Ohio State Innovation Foundation | Vaccines and methods of making and using vaccines for prevention of respiratory syncytial virus (rsv) infections |
| EP3823654B1 (en) * | 2018-07-17 | 2024-02-14 | Yale University | Methods for treatment of cancer using chikungunya-vsv chimeric virus |
| US12090235B2 (en) | 2018-09-20 | 2024-09-17 | Modernatx, Inc. | Preparation of lipid nanoparticles and methods of administration thereof |
| CN113939282A (zh) | 2019-01-31 | 2022-01-14 | 摩登纳特斯有限公司 | 制备脂质纳米颗粒的方法 |
| MA55321A (fr) | 2019-03-15 | 2022-01-19 | Modernatx Inc | Vaccins à base d'arn contre le vih |
| CN115612674B (zh) * | 2021-07-14 | 2026-01-30 | 上海荣瑞医药科技有限公司 | 一种溶瘤病毒及其用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7153510B1 (en) * | 1995-05-04 | 2006-12-26 | Yale University | Recombinant vesiculoviruses and their uses |
| ATE468859T1 (de) | 2003-03-26 | 2010-06-15 | Wyeth Llc | Immunogene zusammensetzung und verfahren |
| CN101087886B (zh) * | 2004-04-09 | 2013-07-17 | 惠氏公司 | 疱疹性口炎病毒、其载体和其免疫原性组合物的协同减毒 |
| EP1756287B1 (en) * | 2004-04-09 | 2015-02-25 | Wyeth LLC | Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof |
| WO2009016433A2 (en) * | 2006-09-15 | 2009-02-05 | Ottawa Health Research Institute | Oncolytic rhabdovirus |
| ES2708856T3 (es) * | 2007-08-03 | 2019-04-11 | Pasteur Institut | Vectores de transferencia de gen lentivírico y sus aplicaciones medicinales |
| WO2009114207A2 (en) * | 2008-03-14 | 2009-09-17 | Sanofi Pasteur Biologics Co. | Replication-defective flavivirus vaccines and vaccine vectors |
| WO2010105347A1 (en) * | 2009-03-16 | 2010-09-23 | Mcmaster University | Vaccination methods |
| KR101723900B1 (ko) * | 2009-06-08 | 2017-04-07 | 더 유니버시티 오브 웨스트 온타리오 | 면역화 요법용 발현 벡터로서의 수포성 구내염 바이러스의 상이한 혈청형 |
| PT3351636T (pt) * | 2010-05-14 | 2020-09-24 | Univ Oregon Health & Science | Vectores de hcmv e rhcmv recombinantes codificadores de um antigénio heterólogo isolado a partir de um vírus paramyxoviridae e seus usos |
| US20130095556A1 (en) * | 2011-09-21 | 2013-04-18 | International Aids Vaccine Initiative | Novel vesicular stomatitis virus and virus rescue system |
-
2015
- 2015-02-27 AU AU2015225553A patent/AU2015225553B2/en not_active Ceased
- 2015-02-27 EP EP15758863.3A patent/EP3113795B1/en active Active
- 2015-02-27 KR KR1020167027395A patent/KR102416194B1/ko not_active Expired - Fee Related
- 2015-02-27 JP JP2016555578A patent/JP2017508465A/ja active Pending
- 2015-02-27 MX MX2016011300A patent/MX369776B/es active IP Right Grant
- 2015-02-27 DK DK15758863.3T patent/DK3113795T3/da active
- 2015-02-27 ES ES15758863T patent/ES2749381T3/es active Active
- 2015-02-27 WO PCT/US2015/018156 patent/WO2015134332A2/en not_active Ceased
- 2015-02-27 SG SG11201607287XA patent/SG11201607287XA/en unknown
- 2015-02-27 US US15/122,695 patent/US9932564B2/en active Active
- 2015-02-27 CN CN201580026511.3A patent/CN106794240A/zh active Pending
- 2015-02-27 CA CA2941261A patent/CA2941261A1/en active Pending
-
2016
- 2016-08-30 IL IL247545A patent/IL247545B/en unknown
- 2016-08-31 ZA ZA2016/06036A patent/ZA201606036B/en unknown
-
2020
- 2020-02-03 JP JP2020015937A patent/JP7454393B2/ja active Active
-
2022
- 2022-01-31 IL IL290258A patent/IL290258A/en unknown
- 2022-06-14 JP JP2022095401A patent/JP2022126723A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10646557B2 (en) | Vaccine composition | |
| Cohen et al. | Modulating the immune response to genetic immunization | |
| AU2017297610B2 (en) | Compositions and methods for alphavirus vaccination | |
| Chattergoon | Genetic immunization: a new era in vaccines and immune therapeutics | |
| JP2019526580A5 (cg-RX-API-DMAC10.html) | ||
| US9630996B2 (en) | Attenuated recombinant vesicular stomatitis viruses comprising modified mutant matrix proteins | |
| WO2015106697A1 (zh) | 免疫增强的人乳头瘤病毒感染及相关疾病的治疗性疫苗 | |
| JP2010500399A5 (cg-RX-API-DMAC10.html) | ||
| JP2008508866A5 (cg-RX-API-DMAC10.html) | ||
| JP2016128513A5 (cg-RX-API-DMAC10.html) | ||
| JP2008530245A5 (cg-RX-API-DMAC10.html) | ||
| WO2003031602A1 (en) | The oncolytic microorganisms expressing hsp and uses thereof | |
| JP2006523224A (ja) | 免疫原性組成物および方法 | |
| CN105906721A (zh) | 一种水痘-带状疱疹病毒gB-gE-gH-gL融合蛋白、基因工程亚单位疫苗及制备方法 | |
| JP2025094154A5 (cg-RX-API-DMAC10.html) | ||
| CN113226364A (zh) | 组合物和方法 | |
| JP2024544566A5 (cg-RX-API-DMAC10.html) | ||
| Gupta et al. | Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag | |
| US11160857B2 (en) | Multivalent enterovirus vaccine compositions and uses related thereto | |
| RU2015121429A (ru) | Химерные антигены для вакцины против вируса гепатита с | |
| WO2025081515A1 (zh) | 一种特异性标记异源蛋白的肿瘤新抗原疫苗体系及其应用 | |
| CN104744594B (zh) | 乙肝病毒多表位与志贺毒素的融合蛋白及其制备方法和应用 | |
| CN105198982A (zh) | 基于il-6的抗原表位及其应用 | |
| Xie et al. | Co-administration of antigen with chemokine MCP-3 or MDC/CCL22 enhances DNA vaccine potency | |
| WO2007093134A1 (en) | Aids vaccine based on replicative vaccinia virus vector |